PGF and neoplasm: Pharmacodynamics of blood based sVEGFR1, sVEGFR2, PlGF, VEGF, cytokine signature, and CECs may also be useful to monitor the target effect, tumour response and treatment outcome in response to anti-VEGF therapies and immunotherapy [15,21,22,23,24,31,32,36].